Patient and institutional factors associated with postoperative opioid prescribing after common vascular procedures

Edward D. Gifford, Kristine T. Hanson, Victor J. Davila, Warren A. Oldenburg, Jill J. Colglazier, Samuel R. Money, Albert Hakaim, William M. Stone, Houssam Farres, Elizabeth B Habermann, Manju Kalra, Richard J. Fowl, Gustavo Oderich, Fahad Shuja, Thomas C. Bower, Randall R De Martino

Research output: Contribution to journalArticle

Abstract

Objective: Overprescription of postoperative opioid medication is a major contributor to the opioid abuse epidemic in the United States. Research into prescribing practices has suggested that patients be limited to 7 days or <200 morphine milligram equivalents (MME) after surgical procedures. Our aim was to identify patient or institutional factors associated with increased opioid prescriptions. Methods: Opioid naive patients from an integrated health system undergoing one of nine surgical and endovascular procedures tracked within the Vascular Quality Initiative from 2015 to 2017 were identified and matched to their discharge and refill opioid prescriptions. Discharge opioid prescriptions were converted to MME. The primary outcome was discharge MME >200, and secondary outcomes were procedure-specific top-quartile opioid prescription and medication refills. Multivariable logistic regression was used to assess patient and perioperative factors associated with each outcome. Results: Among 1546 opioid naive patients, 739 (48%) received a discharge opioid prescription; median MME was 0 (interquartile range, 0-150), and 349 (23%) had >200 MME. Among those with a discharge prescription, median MME was 180 (interquartile range, 150-300). MME varied by procedure (P < .001), with highest MME after suprainguinal bypass (median, 225) and infrainguinal bypass (200) and lowest MME after carotid artery stenting, carotid endarterectomy, and percutaneous peripheral vascular intervention (all medians of 0). On multivariable analysis, factors associated with MME >200 included younger patient age (<65 vs ≥ 80 years; odds ratio [OR], 3.0; 95% confidence interval [CI], 1.9-4.6; P < .001), treating institution B vs A (OR, 3.50; 95% CI, 2.42-5.07; P < .001) and C vs A (OR, 3.90; 95% CI, 2.66-5.74; P < .001), procedure-specific top-quartile length of stay (OR, 1.45; 95% CI, 1.01-2.08; P = .047), and prior tobacco use (OR, 1.60; 95% CI, 1.07-2.37; P = .02). The same variables along with current tobacco use and lack of preoperative aspirin were associated with procedure-specific top-quartile MME at discharge. Chronic beta-blocker use was protective of top-quartile MME. Based on the observed variability, an institutional standard for opioid prescribing has been developed for standardization. Conclusions: Opioid prescriptions at discharge vary with the invasiveness of vascular surgical procedures. Less than 25% of patients receive >200 MME. Variation by center represents a lack of standardization in prescribing practices and an opportunity for further improvement based on developed guidelines. Patient factors and procedure type can alert clinicians to patients at risk of higher than recommended MME.

Original languageEnglish (US)
JournalJournal of vascular surgery
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Opioid Analgesics
Blood Vessels
Prescriptions
MME
Logistic Models
Guidelines
Research

Keywords

  • Opioids
  • Prescriptions
  • Vascular Quality Initiative

ASJC Scopus subject areas

  • Surgery
  • Cardiology and Cardiovascular Medicine

Cite this

Patient and institutional factors associated with postoperative opioid prescribing after common vascular procedures. / Gifford, Edward D.; Hanson, Kristine T.; Davila, Victor J.; Oldenburg, Warren A.; Colglazier, Jill J.; Money, Samuel R.; Hakaim, Albert; Stone, William M.; Farres, Houssam; Habermann, Elizabeth B; Kalra, Manju; Fowl, Richard J.; Oderich, Gustavo; Shuja, Fahad; Bower, Thomas C.; De Martino, Randall R.

In: Journal of vascular surgery, 01.01.2019.

Research output: Contribution to journalArticle

Gifford, Edward D. ; Hanson, Kristine T. ; Davila, Victor J. ; Oldenburg, Warren A. ; Colglazier, Jill J. ; Money, Samuel R. ; Hakaim, Albert ; Stone, William M. ; Farres, Houssam ; Habermann, Elizabeth B ; Kalra, Manju ; Fowl, Richard J. ; Oderich, Gustavo ; Shuja, Fahad ; Bower, Thomas C. ; De Martino, Randall R. / Patient and institutional factors associated with postoperative opioid prescribing after common vascular procedures. In: Journal of vascular surgery. 2019.
@article{f9e030e7a339496884d416ff62cdd780,
title = "Patient and institutional factors associated with postoperative opioid prescribing after common vascular procedures",
abstract = "Objective: Overprescription of postoperative opioid medication is a major contributor to the opioid abuse epidemic in the United States. Research into prescribing practices has suggested that patients be limited to 7 days or <200 morphine milligram equivalents (MME) after surgical procedures. Our aim was to identify patient or institutional factors associated with increased opioid prescriptions. Methods: Opioid naive patients from an integrated health system undergoing one of nine surgical and endovascular procedures tracked within the Vascular Quality Initiative from 2015 to 2017 were identified and matched to their discharge and refill opioid prescriptions. Discharge opioid prescriptions were converted to MME. The primary outcome was discharge MME >200, and secondary outcomes were procedure-specific top-quartile opioid prescription and medication refills. Multivariable logistic regression was used to assess patient and perioperative factors associated with each outcome. Results: Among 1546 opioid naive patients, 739 (48{\%}) received a discharge opioid prescription; median MME was 0 (interquartile range, 0-150), and 349 (23{\%}) had >200 MME. Among those with a discharge prescription, median MME was 180 (interquartile range, 150-300). MME varied by procedure (P < .001), with highest MME after suprainguinal bypass (median, 225) and infrainguinal bypass (200) and lowest MME after carotid artery stenting, carotid endarterectomy, and percutaneous peripheral vascular intervention (all medians of 0). On multivariable analysis, factors associated with MME >200 included younger patient age (<65 vs ≥ 80 years; odds ratio [OR], 3.0; 95{\%} confidence interval [CI], 1.9-4.6; P < .001), treating institution B vs A (OR, 3.50; 95{\%} CI, 2.42-5.07; P < .001) and C vs A (OR, 3.90; 95{\%} CI, 2.66-5.74; P < .001), procedure-specific top-quartile length of stay (OR, 1.45; 95{\%} CI, 1.01-2.08; P = .047), and prior tobacco use (OR, 1.60; 95{\%} CI, 1.07-2.37; P = .02). The same variables along with current tobacco use and lack of preoperative aspirin were associated with procedure-specific top-quartile MME at discharge. Chronic beta-blocker use was protective of top-quartile MME. Based on the observed variability, an institutional standard for opioid prescribing has been developed for standardization. Conclusions: Opioid prescriptions at discharge vary with the invasiveness of vascular surgical procedures. Less than 25{\%} of patients receive >200 MME. Variation by center represents a lack of standardization in prescribing practices and an opportunity for further improvement based on developed guidelines. Patient factors and procedure type can alert clinicians to patients at risk of higher than recommended MME.",
keywords = "Opioids, Prescriptions, Vascular Quality Initiative",
author = "Gifford, {Edward D.} and Hanson, {Kristine T.} and Davila, {Victor J.} and Oldenburg, {Warren A.} and Colglazier, {Jill J.} and Money, {Samuel R.} and Albert Hakaim and Stone, {William M.} and Houssam Farres and Habermann, {Elizabeth B} and Manju Kalra and Fowl, {Richard J.} and Gustavo Oderich and Fahad Shuja and Bower, {Thomas C.} and {De Martino}, {Randall R}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.jvs.2019.05.068",
language = "English (US)",
journal = "Journal of Vascular Surgery",
issn = "0741-5214",
publisher = "Mosby Inc.",

}

TY - JOUR

T1 - Patient and institutional factors associated with postoperative opioid prescribing after common vascular procedures

AU - Gifford, Edward D.

AU - Hanson, Kristine T.

AU - Davila, Victor J.

AU - Oldenburg, Warren A.

AU - Colglazier, Jill J.

AU - Money, Samuel R.

AU - Hakaim, Albert

AU - Stone, William M.

AU - Farres, Houssam

AU - Habermann, Elizabeth B

AU - Kalra, Manju

AU - Fowl, Richard J.

AU - Oderich, Gustavo

AU - Shuja, Fahad

AU - Bower, Thomas C.

AU - De Martino, Randall R

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objective: Overprescription of postoperative opioid medication is a major contributor to the opioid abuse epidemic in the United States. Research into prescribing practices has suggested that patients be limited to 7 days or <200 morphine milligram equivalents (MME) after surgical procedures. Our aim was to identify patient or institutional factors associated with increased opioid prescriptions. Methods: Opioid naive patients from an integrated health system undergoing one of nine surgical and endovascular procedures tracked within the Vascular Quality Initiative from 2015 to 2017 were identified and matched to their discharge and refill opioid prescriptions. Discharge opioid prescriptions were converted to MME. The primary outcome was discharge MME >200, and secondary outcomes were procedure-specific top-quartile opioid prescription and medication refills. Multivariable logistic regression was used to assess patient and perioperative factors associated with each outcome. Results: Among 1546 opioid naive patients, 739 (48%) received a discharge opioid prescription; median MME was 0 (interquartile range, 0-150), and 349 (23%) had >200 MME. Among those with a discharge prescription, median MME was 180 (interquartile range, 150-300). MME varied by procedure (P < .001), with highest MME after suprainguinal bypass (median, 225) and infrainguinal bypass (200) and lowest MME after carotid artery stenting, carotid endarterectomy, and percutaneous peripheral vascular intervention (all medians of 0). On multivariable analysis, factors associated with MME >200 included younger patient age (<65 vs ≥ 80 years; odds ratio [OR], 3.0; 95% confidence interval [CI], 1.9-4.6; P < .001), treating institution B vs A (OR, 3.50; 95% CI, 2.42-5.07; P < .001) and C vs A (OR, 3.90; 95% CI, 2.66-5.74; P < .001), procedure-specific top-quartile length of stay (OR, 1.45; 95% CI, 1.01-2.08; P = .047), and prior tobacco use (OR, 1.60; 95% CI, 1.07-2.37; P = .02). The same variables along with current tobacco use and lack of preoperative aspirin were associated with procedure-specific top-quartile MME at discharge. Chronic beta-blocker use was protective of top-quartile MME. Based on the observed variability, an institutional standard for opioid prescribing has been developed for standardization. Conclusions: Opioid prescriptions at discharge vary with the invasiveness of vascular surgical procedures. Less than 25% of patients receive >200 MME. Variation by center represents a lack of standardization in prescribing practices and an opportunity for further improvement based on developed guidelines. Patient factors and procedure type can alert clinicians to patients at risk of higher than recommended MME.

AB - Objective: Overprescription of postoperative opioid medication is a major contributor to the opioid abuse epidemic in the United States. Research into prescribing practices has suggested that patients be limited to 7 days or <200 morphine milligram equivalents (MME) after surgical procedures. Our aim was to identify patient or institutional factors associated with increased opioid prescriptions. Methods: Opioid naive patients from an integrated health system undergoing one of nine surgical and endovascular procedures tracked within the Vascular Quality Initiative from 2015 to 2017 were identified and matched to their discharge and refill opioid prescriptions. Discharge opioid prescriptions were converted to MME. The primary outcome was discharge MME >200, and secondary outcomes were procedure-specific top-quartile opioid prescription and medication refills. Multivariable logistic regression was used to assess patient and perioperative factors associated with each outcome. Results: Among 1546 opioid naive patients, 739 (48%) received a discharge opioid prescription; median MME was 0 (interquartile range, 0-150), and 349 (23%) had >200 MME. Among those with a discharge prescription, median MME was 180 (interquartile range, 150-300). MME varied by procedure (P < .001), with highest MME after suprainguinal bypass (median, 225) and infrainguinal bypass (200) and lowest MME after carotid artery stenting, carotid endarterectomy, and percutaneous peripheral vascular intervention (all medians of 0). On multivariable analysis, factors associated with MME >200 included younger patient age (<65 vs ≥ 80 years; odds ratio [OR], 3.0; 95% confidence interval [CI], 1.9-4.6; P < .001), treating institution B vs A (OR, 3.50; 95% CI, 2.42-5.07; P < .001) and C vs A (OR, 3.90; 95% CI, 2.66-5.74; P < .001), procedure-specific top-quartile length of stay (OR, 1.45; 95% CI, 1.01-2.08; P = .047), and prior tobacco use (OR, 1.60; 95% CI, 1.07-2.37; P = .02). The same variables along with current tobacco use and lack of preoperative aspirin were associated with procedure-specific top-quartile MME at discharge. Chronic beta-blocker use was protective of top-quartile MME. Based on the observed variability, an institutional standard for opioid prescribing has been developed for standardization. Conclusions: Opioid prescriptions at discharge vary with the invasiveness of vascular surgical procedures. Less than 25% of patients receive >200 MME. Variation by center represents a lack of standardization in prescribing practices and an opportunity for further improvement based on developed guidelines. Patient factors and procedure type can alert clinicians to patients at risk of higher than recommended MME.

KW - Opioids

KW - Prescriptions

KW - Vascular Quality Initiative

UR - http://www.scopus.com/inward/record.url?scp=85071969878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071969878&partnerID=8YFLogxK

U2 - 10.1016/j.jvs.2019.05.068

DO - 10.1016/j.jvs.2019.05.068

M3 - Article

AN - SCOPUS:85071969878

JO - Journal of Vascular Surgery

JF - Journal of Vascular Surgery

SN - 0741-5214

ER -